Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.
Follow DHR
Danaher Corporation (DHR) Total debt
Danaher Corporation's total debt at the end of fiscal 2025 was $18.4B, up 18.8% from $15.5B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $25.1B. Over the past ten years it has ranged from $9.7B (fiscal 2016) to $22.2B (fiscal 2021); the current reading is higher than 64% of that period. Danaher Corporation ranks 2nd of 50 Diagnostics & Research companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $18.4B | 18.81% |
| FY2024 | $15.5B | (7.22%) |
| FY2023 | $16.7B | (12.46%) |
| FY2022 | $19.1B | (13.90%) |
| FY2021 | $22.2B | 4.60% |
| FY2020 | $21.2B | (1.51%) |
| FY2019 | $21.5B | 122.09% |
| FY2018 | $9.7B | (6.19%) |
| FY2017 | $10.3B | 6.75% |
| FY2016 | $9.7B | (19.55%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $25.1B | 43.20% |
| Mar 2026 | $17.6B | (4.64%) |
| Dec 2025 | $18.4B | 9.40% |
| Sep 2025 | $16.8B | (0.12%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| TMO Thermo Fisher Scientific Inc. compare | $39.2B |
| DHR Danaher Corporation | $25.1B |
| IQV IQVIA Holdings Inc. compare | $16.0B |
| WAT Waters Corporation compare | $4.9B |
| A Agilent Technologies, Inc. compare | $3.6B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| ILMN Illumina, Inc. compare | $1.5B |
| IDXX IDEXX Laboratories, Inc. compare | $449.9M |
| NTRA Natera, Inc. compare | $80.3M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement